Peptide Profile
Retinalamin
Retinal bioregulator · Khavinson retinal peptide · bovine retina peptide
Retinalamin is a polypeptide bioregulator preparation derived from retinal tissue, classified as a Khavinson-class agent investigated for neuroprotective and anti-aging effects in photoreceptors and retinal ganglion cells,…
- Half-life
- Unknown
- Routes
- parabulbar injection, intramuscular
Educational research information — not medical advice. Review primary sources and consult a qualified professional before any decision.
Educational research tools — not medical advice.
What Retinalamin is
About Retinalamin
Polypeptide bioregulator from bovine retina; normalizes retinal pigment epithelial and photoreceptor cell function; reduces oxidative damage in retinal tissue
Retinalamin is a polypeptide bioregulator preparation derived from retinal tissue, classified as a Khavinson-class agent investigated for neuroprotective and anti-aging effects in photoreceptors and retinal ganglion cells, proposed to support visual function by modulating gene expression and cellular homeostasis in aging retinal tissue. Like other Khavinson bioregulator preparations, retinalamin is proposed to exert tissue-specific regulatory effects through intracellular transport of ultrashort active peptide components via amino acid carrier mechanisms, modulating transcriptional activity in retinal pigment epithelium and photoreceptor cells under degenerative or age-related stress conditions. Published research on Khavinson-class ultrashort peptides has characterized intracellular transport mechanisms via POT and LAT carriers and neuroepigenetic regulatory actions in aging neural tissue, providing the class-level mechanistic framework within which retinalamin's retinal effects are proposed. Retinalamin has no FDA approval; it is used as a clinical preparation in Russia and Eastern Europe for degenerative retinal conditions, and its evidence base derives from Russian-origin preclinical and observational studies that have not been independently replicated in Western-indexed clinical literature.
Retinalamin Benefits & Research Areas
Research Signals
Population research notes
These signals reflect research interest areas, not treatment indications.
What the evidence says about Retinalamin
Research Evidence
based on 2 studies · most recent 2022
Regulatory Status
- Availability Status
- Research Only
- FDA Status
- Not Evaluated
Russian retinal peptide bioregulator (Khavinson Institute). Used in Russia for age-related retinal degeneration. Not FDA-approved. Not available in US except as research chemical.
Regulatory status reflects publicly available information and may change. This is not legal or medical advice.
Research Sources
2 sources cited · 2 weak
2 Reviews
Bioavailability and Biological Activities of Food-Derived Di- and Tripeptides: In Silico and In Vitro Studies
International Journal of Molecular Sciences · 2022
This review examines the bioavailability and biological activities of short peptides including retinalamin and related retinal peptide regulators, providing mechanistic context for their documented effects on retinal tissue protection and age-related degenerative changes in the eye.
Peptide Regulation of Gene Expression and Protein Synthesis in Bronchial Epithelium
International Journal of Molecular Sciences · 2022
This review documents the cellular uptake mechanisms of short regulatory peptides including retinalamin via POT and LAT transporter systems, demonstrating nuclear translocation and chromatin binding activity relevant to retinalamin's transcriptional regulatory function in retinal tissue cells.
Retinalamin Side Effects & Safety Considerations
Research-use compound with limited human data. Evidence strength varies — see the Evidence section.
Reported (unverified — pending clinical review)
No established clinical contraindications
Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.
Compare
VSRetinalamin
Frequently Asked Questions — Retinalamin
Retinalamin is a polypeptide bioregulator preparation derived from retinal tissue, classified as a Khavinson-class agent investigated for neuroprotective and anti-aging effects in photoreceptors and retinal ganglion cells, proposed to support visual function by modulating gene expression and cellular homeostasis in aging retinal tissue. Like other Khavinson bioregulator preparations, retinalamin is proposed to exert tissue-specific regulatory effects through intracellular transport of ultrashort active peptide components via amino acid carrier mechanisms, modulating transcriptional activity in retinal pigment epithelium and photoreceptor cells under degenerative or age-related stress conditions.
retinal cell protection, visual function restoration, macular degeneration support, anti-aging (eyes).
Research on Retinalamin primarily documents effects related to retinal cell protection and visual function restoration and macular degeneration support and anti-aging (eyes). These are areas covered in preclinical and clinical literature — individual response varies and effects depend on context of use.
Reported contraindications and considerations for Retinalamin include bovine protein allergy. This is educational information only — consult a qualified healthcare professional before use.
For Retinalamin, its FDA status is not evaluated by the FDA, and it is designated for research use only. Regulatory status reflects publicly available information and may change. This is not legal or medical advice.
1 provider in the directory currently offers Retinalamin.
How to get Retinalamin
Where to buy Retinalamin
1 providerClinics
1 providerQuestions to ask your provider
Stay updated on Retinalamin providers
New providers added weekly — delivered to your inbox.
Last updated
Keep exploring
Tools & Guides
Reconstitution Calculator
Convert vial size + BAC water volume into draw volume.
How to Reconstitute Peptides
Step-by-step guide: BAC water, vial prep, and storage after mixing.
Peptide Dosage Guide
Key factors that determine dosing in clinical practice.
Peptide Storage Guide
How to store lyophilized and reconstituted peptides.